{
  "docId": "019de072-75de-708e-aad9-55788df6c953",
  "docSlug": "5188528054c3088b6a98b04815eb3ce3",
  "documentTitle": "AstraZeneca | Results Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 40,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "key_messages",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "Includes a detailed list of abbreviations in the footer.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-75de-708e-aad9-55788df6c953/7",
  "deckHref": "/decks/019de072-75de-708e-aad9-55788df6c953",
  "deckJsonHref": "/decks/019de072-75de-708e-aad9-55788df6c953.json",
  "deckAnchorHref": "/decks/019de072-75de-708e-aad9-55788df6c953#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.58,
        "x": 0.38,
        "y": 0.24
      },
      "kind": "diagram",
      "text": "Well positioned to deliver growth 2025+: Robust lifecycle management, Innovative late-stage pipeline, Strategic business development, Attractive loss of exclusivity (LoE) profile",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7777949f-c761-4996-988d-3dbd78bb520f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.33,
        "x": 0.03,
        "y": 0.35
      },
      "kind": "list",
      "text": "H1 2022: Farxiga, Ultomiris, eplontersen; H2 2022: Imfinzi, capivasertib, Imfinzi",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c15514c6-4319-4a9f-bba8-8166c120184c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.33,
        "x": 0.03,
        "y": 0.24
      },
      "kind": "list",
      "text": "Pipeline momentum: Key 2022 Phase III readouts",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa28a1b6-b73d-4a85-8b60-783885fccedb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.93,
        "x": 0.03,
        "y": 0.91
      },
      "kind": "source-note",
      "text": "Planned interim analysis as previously communicated... [abbreviations list]",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6e0d928-7840-4ba5-8929-40f49550ac06",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.58,
        "x": 0.38,
        "y": 0.58
      },
      "kind": "table",
      "text": "Selected next-wave NMEs: BioPharmaceuticals, Oncology, Rare Disease columns with drug lists",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f3fe2ac3-7b65-4cf8-bb4f-92da7666fd8a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "Strong 2022 outlook, poised to deliver durable growth 2025+",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "822165a6-91c4-4ed4-86dc-fd36080ce086",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.21,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "AstraZeneca",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ed7232b-21cf-4900-8508-079a82fc41a1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "action-titles",
      "slug": null,
      "matchId": "1bc1d835-a844-4cde-9328-c18ef33031ea",
      "evidence": "The slide uses a clear, thesis-driven headline.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "b213f952-f7c0-4403-889c-b9a0f8fafa05",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The slides highlight the company's strong top-line growth and variability between quarters",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "633b67bb-9ede-479d-8827-edd694513a87",
      "evidence": "The slides provide KPI overviews and key messages",
      "position": 0,
      "objective": "Highlighting strong top-line growth",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 0.7,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}